Literature DB >> 9356250

A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform.

D Peretz1, R A Williamson, Y Matsunaga, H Serban, C Pinilla, R B Bastidas, R Rozenshteyn, T L James, R A Houghten, F E Cohen, S B Prusiner, D R Burton.   

Abstract

The scrapie prion protein (PrPSc) is formed from the cellular isoform (PrPC) by a post-translational process that involves a profound conformational change. Linear epitopes for recombinant antibody Fab fragments (Fabs) on PrPC and on the protease-resistant core of PrPSc, designated PrP 27-30, were identified using ELISA and immunoprecipitation. An epitope region at the C terminus was accessible in both PrPC and PrP 27-30; in contrast, epitopes towards the N-terminal region (residues 90 to 120) were accessible in PrPC but largely cryptic in PrP 27-30. Denaturation of PrP 27-30 exposed the epitopes of the N-terminal domain. We argue from our findings that the major conformational change underlying PrPSc formation occurs within the N-terminal segment of PrP 27-30. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356250     DOI: 10.1006/jmbi.1997.1328

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  112 in total

1.  Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.

Authors:  E Leclerc; D Peretz; H Ball; H Sakurai; G Legname; A Serban; S B Prusiner; D R Burton; R A Williamson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Structural studies of the scrapie prion protein by electron crystallography.

Authors:  Holger Wille; Melissa D Michelitsch; Vincent Guenebaut; Surachai Supattapone; Ana Serban; Fred E Cohen; David A Agard; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

3.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

4.  Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.

Authors:  S Capellari; P Parchi; C M Russo; J Sanford; M S Sy; P Gambetti; R B Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

5.  Sequence determinants of amyloid fibril formation.

Authors:  Manuela López de la Paz; Luis Serrano
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

6.  Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.

Authors:  Bishwajit Kundu; Nilesh R Maiti; Eric M Jones; Krystyna A Surewicz; David L Vanik; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

7.  Antibody to DNA detects scrapie but not normal prion protein.

Authors:  Wen-Quan Zou; Jian Zheng; Donald M Gray; Pierluigi Gambetti; Shu G Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

8.  Molecular dynamics simulation of dimeric and monomeric forms of human prion protein: insight into dynamics and properties.

Authors:  Masakazu Sekijima; Chie Motono; Satoshi Yamasaki; Kiyotoshi Kaneko; Yutaka Akiyama
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

9.  Folding pathways of prion and doppel.

Authors:  Giovanni Settanni; Trinh Xuan Hoang; Cristian Micheletti; Amos Maritan
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

10.  Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.

Authors:  Denis B D O'Sullivan; Christopher E Jones; Salama R Abdelraheim; Marcus W Brazier; Harold Toms; David R Brown; John H Viles
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.